0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diagnostics of Peripheral Arterial Disease Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-10U13438
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Diagnostics of Peripheral Arterial Disease Market Research Report 2023
BUY CHAPTERS

Global Diagnostics of Peripheral Arterial Disease Market Research Report 2025

Code: QYRE-Auto-10U13438
Report
March 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diagnostics of Peripheral Arterial Disease Market Size

The global market for Diagnostics of Peripheral Arterial Disease was valued at US$ 922 million in the year 2024 and is projected to reach a revised size of US$ 1309 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Diagnostics of Peripheral Arterial Disease Market

Diagnostics of Peripheral Arterial Disease Market

Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostics of Peripheral Arterial Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostics of Peripheral Arterial Disease.
The Diagnostics of Peripheral Arterial Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostics of Peripheral Arterial Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostics of Peripheral Arterial Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Diagnostics of Peripheral Arterial Disease Market Report

Report Metric Details
Report Name Diagnostics of Peripheral Arterial Disease Market
Accounted market size in year US$ 922 million
Forecasted market size in 2031 US$ 1309 million
CAGR 5.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Viasonix, Koven Technology, Natus Medical, Huntleigh, Hokanson, CooperSurgical, Perimed, Atys Medical, Newman Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Diagnostics of Peripheral Arterial Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostics of Peripheral Arterial Disease Market growing?

Ans: The Diagnostics of Peripheral Arterial Disease Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Diagnostics of Peripheral Arterial Disease Market size in 2031?

Ans: The Diagnostics of Peripheral Arterial Disease Market size in 2031 will be US$ 1309 million.

Who are the main players in the Diagnostics of Peripheral Arterial Disease Market report?

Ans: The main players in the Diagnostics of Peripheral Arterial Disease Market are Viasonix, Koven Technology, Natus Medical, Huntleigh, Hokanson, CooperSurgical, Perimed, Atys Medical, Newman Medical

What are the Application segmentation covered in the Diagnostics of Peripheral Arterial Disease Market report?

Ans: The Applications covered in the Diagnostics of Peripheral Arterial Disease Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Diagnostics of Peripheral Arterial Disease Market report?

Ans: The Types covered in the Diagnostics of Peripheral Arterial Disease Market report are Ankle-Brachial Index (ABI), Ultrasonography, Angiography, Other

Recommended Reports

Vascular Diagnostics & Devices

Cardiac & Ischemic Disease

General Diagnostic Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ankle-Brachial Index (ABI)
1.2.3 Ultrasonography
1.2.4 Angiography
1.2.5 Other
1.3 Market by Application
1.3.1 Global Diagnostics of Peripheral Arterial Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostics of Peripheral Arterial Disease Market Perspective (2020-2031)
2.2 Global Diagnostics of Peripheral Arterial Disease Growth Trends by Region
2.2.1 Global Diagnostics of Peripheral Arterial Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diagnostics of Peripheral Arterial Disease Historic Market Size by Region (2020-2025)
2.2.3 Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Region (2026-2031)
2.3 Diagnostics of Peripheral Arterial Disease Market Dynamics
2.3.1 Diagnostics of Peripheral Arterial Disease Industry Trends
2.3.2 Diagnostics of Peripheral Arterial Disease Market Drivers
2.3.3 Diagnostics of Peripheral Arterial Disease Market Challenges
2.3.4 Diagnostics of Peripheral Arterial Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostics of Peripheral Arterial Disease Players by Revenue
3.1.1 Global Top Diagnostics of Peripheral Arterial Disease Players by Revenue (2020-2025)
3.1.2 Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Players (2020-2025)
3.2 Global Diagnostics of Peripheral Arterial Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diagnostics of Peripheral Arterial Disease Revenue
3.4 Global Diagnostics of Peripheral Arterial Disease Market Concentration Ratio
3.4.1 Global Diagnostics of Peripheral Arterial Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostics of Peripheral Arterial Disease Revenue in 2024
3.5 Global Key Players of Diagnostics of Peripheral Arterial Disease Head office and Area Served
3.6 Global Key Players of Diagnostics of Peripheral Arterial Disease, Product and Application
3.7 Global Key Players of Diagnostics of Peripheral Arterial Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostics of Peripheral Arterial Disease Breakdown Data by Type
4.1 Global Diagnostics of Peripheral Arterial Disease Historic Market Size by Type (2020-2025)
4.2 Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Type (2026-2031)
5 Diagnostics of Peripheral Arterial Disease Breakdown Data by Application
5.1 Global Diagnostics of Peripheral Arterial Disease Historic Market Size by Application (2020-2025)
5.2 Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diagnostics of Peripheral Arterial Disease Market Size (2020-2031)
6.2 North America Diagnostics of Peripheral Arterial Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diagnostics of Peripheral Arterial Disease Market Size by Country (2020-2025)
6.4 North America Diagnostics of Peripheral Arterial Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostics of Peripheral Arterial Disease Market Size (2020-2031)
7.2 Europe Diagnostics of Peripheral Arterial Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diagnostics of Peripheral Arterial Disease Market Size by Country (2020-2025)
7.4 Europe Diagnostics of Peripheral Arterial Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size (2020-2031)
8.2 Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostics of Peripheral Arterial Disease Market Size (2020-2031)
9.2 Latin America Diagnostics of Peripheral Arterial Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diagnostics of Peripheral Arterial Disease Market Size by Country (2020-2025)
9.4 Latin America Diagnostics of Peripheral Arterial Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size (2020-2031)
10.2 Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Viasonix
11.1.1 Viasonix Company Details
11.1.2 Viasonix Business Overview
11.1.3 Viasonix Diagnostics of Peripheral Arterial Disease Introduction
11.1.4 Viasonix Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.1.5 Viasonix Recent Development
11.2 Koven Technology
11.2.1 Koven Technology Company Details
11.2.2 Koven Technology Business Overview
11.2.3 Koven Technology Diagnostics of Peripheral Arterial Disease Introduction
11.2.4 Koven Technology Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.2.5 Koven Technology Recent Development
11.3 Natus Medical
11.3.1 Natus Medical Company Details
11.3.2 Natus Medical Business Overview
11.3.3 Natus Medical Diagnostics of Peripheral Arterial Disease Introduction
11.3.4 Natus Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.3.5 Natus Medical Recent Development
11.4 Huntleigh
11.4.1 Huntleigh Company Details
11.4.2 Huntleigh Business Overview
11.4.3 Huntleigh Diagnostics of Peripheral Arterial Disease Introduction
11.4.4 Huntleigh Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.4.5 Huntleigh Recent Development
11.5 Hokanson
11.5.1 Hokanson Company Details
11.5.2 Hokanson Business Overview
11.5.3 Hokanson Diagnostics of Peripheral Arterial Disease Introduction
11.5.4 Hokanson Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.5.5 Hokanson Recent Development
11.6 CooperSurgical
11.6.1 CooperSurgical Company Details
11.6.2 CooperSurgical Business Overview
11.6.3 CooperSurgical Diagnostics of Peripheral Arterial Disease Introduction
11.6.4 CooperSurgical Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.6.5 CooperSurgical Recent Development
11.7 Perimed
11.7.1 Perimed Company Details
11.7.2 Perimed Business Overview
11.7.3 Perimed Diagnostics of Peripheral Arterial Disease Introduction
11.7.4 Perimed Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.7.5 Perimed Recent Development
11.8 Atys Medical
11.8.1 Atys Medical Company Details
11.8.2 Atys Medical Business Overview
11.8.3 Atys Medical Diagnostics of Peripheral Arterial Disease Introduction
11.8.4 Atys Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.8.5 Atys Medical Recent Development
11.9 Newman Medical
11.9.1 Newman Medical Company Details
11.9.2 Newman Medical Business Overview
11.9.3 Newman Medical Diagnostics of Peripheral Arterial Disease Introduction
11.9.4 Newman Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
11.9.5 Newman Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Ankle-Brachial Index (ABI)
 Table 3. Key Players of Ultrasonography
 Table 4. Key Players of Angiography
 Table 5. Key Players of Other
 Table 6. Global Diagnostics of Peripheral Arterial Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Diagnostics of Peripheral Arterial Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Diagnostics of Peripheral Arterial Disease Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Diagnostics of Peripheral Arterial Disease Market Share by Region (2020-2025)
 Table 10. Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Diagnostics of Peripheral Arterial Disease Market Share by Region (2026-2031)
 Table 12. Diagnostics of Peripheral Arterial Disease Market Trends
 Table 13. Diagnostics of Peripheral Arterial Disease Market Drivers
 Table 14. Diagnostics of Peripheral Arterial Disease Market Challenges
 Table 15. Diagnostics of Peripheral Arterial Disease Market Restraints
 Table 16. Global Diagnostics of Peripheral Arterial Disease Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Diagnostics of Peripheral Arterial Disease Market Share by Players (2020-2025)
 Table 18. Global Top Diagnostics of Peripheral Arterial Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostics of Peripheral Arterial Disease as of 2024)
 Table 19. Ranking of Global Top Diagnostics of Peripheral Arterial Disease Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Diagnostics of Peripheral Arterial Disease Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Diagnostics of Peripheral Arterial Disease, Headquarters and Area Served
 Table 22. Global Key Players of Diagnostics of Peripheral Arterial Disease, Product and Application
 Table 23. Global Key Players of Diagnostics of Peripheral Arterial Disease, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Diagnostics of Peripheral Arterial Disease Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Type (2020-2025)
 Table 27. Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Type (2026-2031)
 Table 29. Global Diagnostics of Peripheral Arterial Disease Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Application (2020-2025)
 Table 31. Global Diagnostics of Peripheral Arterial Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Diagnostics of Peripheral Arterial Disease Revenue Market Share by Application (2026-2031)
 Table 33. North America Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Diagnostics of Peripheral Arterial Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Diagnostics of Peripheral Arterial Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Diagnostics of Peripheral Arterial Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Diagnostics of Peripheral Arterial Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Diagnostics of Peripheral Arterial Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Diagnostics of Peripheral Arterial Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Viasonix Company Details
 Table 49. Viasonix Business Overview
 Table 50. Viasonix Diagnostics of Peripheral Arterial Disease Product
 Table 51. Viasonix Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 52. Viasonix Recent Development
 Table 53. Koven Technology Company Details
 Table 54. Koven Technology Business Overview
 Table 55. Koven Technology Diagnostics of Peripheral Arterial Disease Product
 Table 56. Koven Technology Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 57. Koven Technology Recent Development
 Table 58. Natus Medical Company Details
 Table 59. Natus Medical Business Overview
 Table 60. Natus Medical Diagnostics of Peripheral Arterial Disease Product
 Table 61. Natus Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 62. Natus Medical Recent Development
 Table 63. Huntleigh Company Details
 Table 64. Huntleigh Business Overview
 Table 65. Huntleigh Diagnostics of Peripheral Arterial Disease Product
 Table 66. Huntleigh Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 67. Huntleigh Recent Development
 Table 68. Hokanson Company Details
 Table 69. Hokanson Business Overview
 Table 70. Hokanson Diagnostics of Peripheral Arterial Disease Product
 Table 71. Hokanson Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 72. Hokanson Recent Development
 Table 73. CooperSurgical Company Details
 Table 74. CooperSurgical Business Overview
 Table 75. CooperSurgical Diagnostics of Peripheral Arterial Disease Product
 Table 76. CooperSurgical Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 77. CooperSurgical Recent Development
 Table 78. Perimed Company Details
 Table 79. Perimed Business Overview
 Table 80. Perimed Diagnostics of Peripheral Arterial Disease Product
 Table 81. Perimed Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 82. Perimed Recent Development
 Table 83. Atys Medical Company Details
 Table 84. Atys Medical Business Overview
 Table 85. Atys Medical Diagnostics of Peripheral Arterial Disease Product
 Table 86. Atys Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 87. Atys Medical Recent Development
 Table 88. Newman Medical Company Details
 Table 89. Newman Medical Business Overview
 Table 90. Newman Medical Diagnostics of Peripheral Arterial Disease Product
 Table 91. Newman Medical Revenue in Diagnostics of Peripheral Arterial Disease Business (2020-2025) & (US$ Million)
 Table 92. Newman Medical Recent Development
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Diagnostics of Peripheral Arterial Disease Picture
 Figure 2. Global Diagnostics of Peripheral Arterial Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diagnostics of Peripheral Arterial Disease Market Share by Type: 2024 VS 2031
 Figure 4. Ankle-Brachial Index (ABI) Features
 Figure 5. Ultrasonography Features
 Figure 6. Angiography Features
 Figure 7. Other Features
 Figure 8. Global Diagnostics of Peripheral Arterial Disease Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Diagnostics of Peripheral Arterial Disease Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Other Case Studies
 Figure 13. Diagnostics of Peripheral Arterial Disease Report Years Considered
 Figure 14. Global Diagnostics of Peripheral Arterial Disease Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Diagnostics of Peripheral Arterial Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Diagnostics of Peripheral Arterial Disease Market Share by Region: 2024 VS 2031
 Figure 17. Global Diagnostics of Peripheral Arterial Disease Market Share by Players in 2024
 Figure 18. Global Top Diagnostics of Peripheral Arterial Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostics of Peripheral Arterial Disease as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Diagnostics of Peripheral Arterial Disease Revenue in 2024
 Figure 20. North America Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Diagnostics of Peripheral Arterial Disease Market Share by Country (2020-2031)
 Figure 22. United States Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Diagnostics of Peripheral Arterial Disease Market Share by Country (2020-2031)
 Figure 26. Germany Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Diagnostics of Peripheral Arterial Disease Market Share by Region (2020-2031)
 Figure 34. China Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Diagnostics of Peripheral Arterial Disease Market Share by Country (2020-2031)
 Figure 42. Mexico Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Diagnostics of Peripheral Arterial Disease Market Share by Country (2020-2031)
 Figure 46. Turkey Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Diagnostics of Peripheral Arterial Disease Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Viasonix Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 50. Koven Technology Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 51. Natus Medical Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 52. Huntleigh Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 53. Hokanson Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 54. CooperSurgical Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 55. Perimed Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 56. Atys Medical Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 57. Newman Medical Revenue Growth Rate in Diagnostics of Peripheral Arterial Disease Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart